Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.

A role for estrogens in breast cancer is widely accepted, however, recent evidence highlights that timing and exposure levels are important in determining whether they elicit harmful versus beneficial effects. The rat chemical carcinogen model has been widely used to study the effects of estrogens b...

Full description

Bibliographic Details
Main Authors: Hillary Stires, Mariana Saboya, Samantha P Globerman, Wendie S Cohick
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5017759?pdf=render
_version_ 1818023315692847104
author Hillary Stires
Mariana Saboya
Samantha P Globerman
Wendie S Cohick
author_facet Hillary Stires
Mariana Saboya
Samantha P Globerman
Wendie S Cohick
author_sort Hillary Stires
collection DOAJ
description A role for estrogens in breast cancer is widely accepted, however, recent evidence highlights that timing and exposure levels are important in determining whether they elicit harmful versus beneficial effects. The rat chemical carcinogen model has been widely used to study the effects of estrogens but conclusions on the levels that lead to tumor development and an absolute requirement for progesterone (P4) are lacking. A newer method of hormone administration mixes hormones with nut butter for peroral consumption allowing for a less stressful method of long-term administration with lower spikes in serum estradiol (E2) levels. The present study was designed to determine if estrogens alone at a physiological dose can drive carcinogen-induced tumors in ovariectomized (OVX) rats or if P4 is also required using this method of hormone administration. Short-term studies were conducted to determine the dose of estrogen (E) that would lead to increased uterine weight following OVX. Subsequently, rats were OVX on postnatal day (PND) 40 then treated daily with E (600 μg/kg/day), P4 (15 mg/kg/day), or the combination. On PND 50, all rats were injected with nitrosomethylurea to induce mammary tumors. Uterine weights, body weights, and serum E2 levels were measured to demonstrate the efficacy of the method for increasing E2 levels during long-term treatment. After 26 weeks, tumor incidence was similar in Sham, E, and E + P4 animals indicating that E was sufficient to induce tumorigenesis when hormone levels were normalized by this method. This study demonstrates peroral administration can be used in long-term studies to elucidate relationships between different types and levels of steroid hormones.
first_indexed 2024-12-10T03:42:22Z
format Article
id doaj.art-b4c7b193a88b456aa4595dd8661df217
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T03:42:22Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b4c7b193a88b456aa4595dd8661df2172022-12-22T02:03:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01119e016266210.1371/journal.pone.0162662Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.Hillary StiresMariana SaboyaSamantha P GlobermanWendie S CohickA role for estrogens in breast cancer is widely accepted, however, recent evidence highlights that timing and exposure levels are important in determining whether they elicit harmful versus beneficial effects. The rat chemical carcinogen model has been widely used to study the effects of estrogens but conclusions on the levels that lead to tumor development and an absolute requirement for progesterone (P4) are lacking. A newer method of hormone administration mixes hormones with nut butter for peroral consumption allowing for a less stressful method of long-term administration with lower spikes in serum estradiol (E2) levels. The present study was designed to determine if estrogens alone at a physiological dose can drive carcinogen-induced tumors in ovariectomized (OVX) rats or if P4 is also required using this method of hormone administration. Short-term studies were conducted to determine the dose of estrogen (E) that would lead to increased uterine weight following OVX. Subsequently, rats were OVX on postnatal day (PND) 40 then treated daily with E (600 μg/kg/day), P4 (15 mg/kg/day), or the combination. On PND 50, all rats were injected with nitrosomethylurea to induce mammary tumors. Uterine weights, body weights, and serum E2 levels were measured to demonstrate the efficacy of the method for increasing E2 levels during long-term treatment. After 26 weeks, tumor incidence was similar in Sham, E, and E + P4 animals indicating that E was sufficient to induce tumorigenesis when hormone levels were normalized by this method. This study demonstrates peroral administration can be used in long-term studies to elucidate relationships between different types and levels of steroid hormones.http://europepmc.org/articles/PMC5017759?pdf=render
spellingShingle Hillary Stires
Mariana Saboya
Samantha P Globerman
Wendie S Cohick
Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
PLoS ONE
title Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
title_full Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
title_fullStr Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
title_full_unstemmed Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
title_short Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone.
title_sort peroral estradiol is sufficient to induce carcinogen induced mammary tumorigenesis in ovariectomized rats without progesterone
url http://europepmc.org/articles/PMC5017759?pdf=render
work_keys_str_mv AT hillarystires peroralestradiolissufficienttoinducecarcinogeninducedmammarytumorigenesisinovariectomizedratswithoutprogesterone
AT marianasaboya peroralestradiolissufficienttoinducecarcinogeninducedmammarytumorigenesisinovariectomizedratswithoutprogesterone
AT samanthapgloberman peroralestradiolissufficienttoinducecarcinogeninducedmammarytumorigenesisinovariectomizedratswithoutprogesterone
AT wendiescohick peroralestradiolissufficienttoinducecarcinogeninducedmammarytumorigenesisinovariectomizedratswithoutprogesterone